500 patients67,039 observations150 daysLIVE

Patient P-03392

Synthetic patientONX-7 · Day 139 · 25–34 · F · baseline S15Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
25%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S15
  2. Day 15 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 18 GI-04 recommendedGI Support Protocol GI-04
  4. Day 19 Patient acceptedStarted GI-04 in the companion
  5. Day 27 GI symptom burden −24% vs expectedGI Support Protocol GI-04
  6. Day 33 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • Treatment adherence-11
  • Nutritional resilience-9
  • GI instability+8
  • Inflammatory activity+8
  • Toxicity+5

What helped?

  • GI Support Protocol GI-04Day 18
    Result: symptom burden −24%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
6.2/10
stable · +0.0 vs previous 14 d
Stress level
Daily log
3.7/10
worsening · +0.2 vs previous 14 d
Pessimism score
Daily log
4.3/10
stable · +0.1 vs previous 14 d
Sleep quality
Wearable
64.5/100
stable · +2.2 vs previous 14 d
Libido
Daily log
5.4/10
stable · +0.1 vs previous 14 d
HRV
Wearable
69.7 ms
stable · -1.7 vs previous 14 d
Toxicity
Blood
12.7/100
worsening · +4.5 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 63 from the failing basin, 28 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -5.4 next day on high-intake days · n 17
Would not help
  • AD-05 Adherence Support
    only 27% improved among 15 similar
  • Keep alcohol low
    GI +4.6 next day on high-intake days · n 21
  • Keep histamine low
    GI +4.4 next day on high-intake days · n 28
  • Keep lactose low
    GI +2.4 next day on high-intake days · n 19
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -5.4supporter · 95%
  • Alcohol
    +4.6detractor · 95%
  • Histamine load
    +4.4detractor · 95%
  • Lactose
    +2.4detractor · 62%
  • Dietary fat load
    -1.5no signal · 34%
  • Caffeine
    -0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 60
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Autonomic recovery 45
    • WearableResting HR 74 bpm
    • Wearable3,270 steps/day
  • Drug metabolism and exposure 35
    • DNADPYD *2A → slower clearance
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Rapid metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2.6 · butyrate capacity 45/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
68 ms
Sleep
7.9 h
Steps
4,362
Resting HR
74 bpm
Daily log: GI score 25, nutritional resilience 60, adherence 89.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0305628%S0584
P-0314228%S1584
P-0339728%S19GI-04no change84
P-0322729%S0383
P-0332429%S1482
P-0319028%S0381
P-0307230%S0381
P-0332229%S0580
P-0302928%S1380
P-0340128%S0480
P-0318728%S12AD-05no change80
P-0323928%S18HY-01no change80